Carfilzomib, Lenalidomide, and Dexamethasone Re-induction Followed by the 2nd ASCT in Multiple Myeloma Patients Relapsed After the 1st ASCT
NCT05497102
Samsung Medical CenterMultiple Myeloma
Start: 2021-11-08End: 2025-12-31Target: 58Updated: 2022-08-12